← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

▼ SELL

$ Value

$382

Shares

40

Price

$10

Filed

Oct 17

Insider

Name

Robertson Jenny

Title

Chief Legal Officer

CIK

0001995009

Roles

Officer

Transaction Details

Transaction Date

2025-10-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

68,930

Footnotes

Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs"). | This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Includes 51,092 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

Filing Info

Accession No.

0001995009-25-000003

Form Type

4

Issuer CIK

0001907108

Robertson Jenny's History

Date Ticker Type Value
2025-11-18 LXEO $5K
2025-10-17 LXEO $31K
2025-10-17 LXEO $382
2025-10-15 LXEO A $0
2025-08-18 LXEO $3K
2025-05-16 LXEO $1K

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$313K 2026-04-06
Otero Jose Manuel
Chief Operating Officer
2026-02-04
Tamayo Louis Edward
Chief Financial Officer
2026-02-04